Roche to pay $100 million for US diagnostics company

Monday 23 August 2010

The Roche Group has announced plans to acquire privately-owned BioImagene Inc of Sunnyvale, California for $100 million in order to bolster its position as a provider of personalised medicines. BioImagene develops digital pathology services.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland